EA201100154A1 - Способ лечения заболеваний толстой кишки - Google Patents
Способ лечения заболеваний толстой кишкиInfo
- Publication number
- EA201100154A1 EA201100154A1 EA201100154A EA201100154A EA201100154A1 EA 201100154 A1 EA201100154 A1 EA 201100154A1 EA 201100154 A EA201100154 A EA 201100154A EA 201100154 A EA201100154 A EA 201100154A EA 201100154 A1 EA201100154 A1 EA 201100154A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- rifalazil
- intestines
- colon
- treating diseases
- bacterial infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Abstract
Предложены способы лечения бактериальной инфекции в толстой кишке и кишечных расстройств, вызванных бактериальной инфекцией, с применением плохо абсорбируемой формы рифалазила. Композиции для орального введения и доставки в толстую кишку не микрогранулированного состава на основе рифалазила также предусмотрены. Рифалазил доставляется в форме, которая плохо абсорбируется в кишечнике после орального дозирования и большая часть введенного орально рифалазила не абсорбируется в кишечнике. Соответственно, антибактериальная активность в кишечной флоре будет увеличиваться, в то время как абсорбция и системная циркуляция будут уменьшаться, тем самым приводя к уменьшению возникновения возможных неблагоприятных эффектов.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7844308P | 2008-07-07 | 2008-07-07 | |
PCT/US2009/049288 WO2010005836A2 (en) | 2008-07-07 | 2009-06-30 | Use of rifalazil to treat colonic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201100154A1 true EA201100154A1 (ru) | 2011-08-30 |
Family
ID=41507676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201100154A EA201100154A1 (ru) | 2008-07-07 | 2009-06-30 | Способ лечения заболеваний толстой кишки |
Country Status (8)
Country | Link |
---|---|
US (1) | US20110117154A1 (ru) |
EP (1) | EP2313099A4 (ru) |
CN (1) | CN102143751A (ru) |
BR (1) | BRPI0910496A2 (ru) |
CA (1) | CA2730274A1 (ru) |
EA (1) | EA201100154A1 (ru) |
MX (1) | MX2011000319A (ru) |
WO (1) | WO2010005836A2 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1400989B1 (it) * | 2010-07-13 | 2013-07-05 | Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L | Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale. |
RU2496475C2 (ru) | 2011-10-26 | 2013-10-27 | Александр Васильевич Иващенко | Фармацевтическая композиция и набор для лечения бактериальных инфекций |
US10501771B2 (en) | 2011-11-08 | 2019-12-10 | The Board Of Regents Of The University Of Texas System | Methods and uses for metabolic profiling for Clostridium difficile infection |
US9758838B2 (en) | 2013-03-12 | 2017-09-12 | Yale University | Compositions and methods for identifying secretory antibody-bound microbes |
WO2016033439A2 (en) | 2014-08-28 | 2016-03-03 | Yale University | Compositions and methods for the treating an inflammatory disease or disorder |
EP3338783B1 (en) | 2014-09-12 | 2024-01-24 | UNION therapeutics A/S | Antibacterial use of halogenated salicylanilides |
CN104644572B (zh) * | 2015-01-27 | 2017-10-03 | 华北制药股份有限公司 | 一种高纯度克林霉素磷酸酯粉针剂及其制备工艺 |
GB201509326D0 (en) * | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
WO2018069938A1 (en) * | 2016-10-14 | 2018-04-19 | Cipla Limited | Pharmaceutical compositions comprising rifaximin |
US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1304363C (en) * | 1988-11-01 | 1992-06-30 | Takehiko Yamane | 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
DE69322764T2 (de) * | 1992-10-09 | 1999-05-06 | Kanegafuchi Chemical Ind | Herstellungsmethode für feines granulat |
AU2002364562A1 (en) * | 2001-12-13 | 2003-06-30 | Activbiotics, Inc. | Metal complexes and formulations of rifamycin analogues and uses therof |
ATE448775T1 (de) * | 2002-08-29 | 2009-12-15 | Activbiotics Pharma Llc | Rifalazil zur behandlung von infektionen mit clostridium difficile |
US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
-
2009
- 2009-06-30 WO PCT/US2009/049288 patent/WO2010005836A2/en active Application Filing
- 2009-06-30 EA EA201100154A patent/EA201100154A1/ru unknown
- 2009-06-30 BR BRPI0910496A patent/BRPI0910496A2/pt not_active IP Right Cessation
- 2009-06-30 CA CA2730274A patent/CA2730274A1/en not_active Abandoned
- 2009-06-30 CN CN200980134800XA patent/CN102143751A/zh active Pending
- 2009-06-30 US US13/002,702 patent/US20110117154A1/en not_active Abandoned
- 2009-06-30 EP EP09794984A patent/EP2313099A4/en not_active Withdrawn
- 2009-06-30 MX MX2011000319A patent/MX2011000319A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2010005836A2 (en) | 2010-01-14 |
EP2313099A4 (en) | 2011-08-10 |
WO2010005836A9 (en) | 2010-04-01 |
EP2313099A2 (en) | 2011-04-27 |
CN102143751A (zh) | 2011-08-03 |
US20110117154A1 (en) | 2011-05-19 |
BRPI0910496A2 (pt) | 2016-08-02 |
CA2730274A1 (en) | 2010-01-14 |
WO2010005836A3 (en) | 2010-05-20 |
MX2011000319A (es) | 2011-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201100154A1 (ru) | Способ лечения заболеваний толстой кишки | |
EA201290171A1 (ru) | Вводимые перорально кортикостероидные композиции | |
MX2009002314A (es) | Composiciones farmaceuticas que comprenden hgh para suministro oral. | |
MX344476B (es) | Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal. | |
EA201590835A1 (ru) | Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием | |
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
EP3904502A3 (en) | Compositions and methods | |
MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
NZ600167A (en) | Concentrated therapeutic phospholipid compositions | |
EA201390305A1 (ru) | Композиции для влагалищного и перорального введения lactobacillus и их применение | |
NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
MX352647B (es) | Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato. | |
EA201171088A1 (ru) | Лечение дискинезии при различных расстройствах | |
BR112012016543A2 (pt) | Tratamento com vb-201 | |
EP2043637A4 (en) | METHOD AND MEDICAMENTS FOR THE ADMINISTRATION OF IBUPROFEN | |
EA201000854A1 (ru) | Применение эдта и ее солей для профилактики и лечения дизентерии свиней и усиления эффектов антибиотиков, проявляющихся при этом заболевании | |
FI2683245T4 (fi) | Menetelmiä ja koostumuksia masennuksen hoitamiseen syklobentsapriiniä käyttämällä | |
EP2575456A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ECCHYMOSIS | |
JP2014505679A5 (ru) | ||
PE20130308A1 (es) | Metodos para tratar infecciones bacterianas recurrentes | |
NZ602032A (en) | Oral b12 therapy | |
MX2014003093A (es) | Combinacion de pterostilbeno y estatina para el tratamiento de enfermedad metabolica, enfermedad cardiovascular e inflamacion. | |
BR112015028581A2 (pt) | composição farmacêutica de dosagem baixa, utilização do ácido, método para o tratamento da doença inflamatória e composição farmacêutica | |
RU2013126798A (ru) | Комбинированная терапия дексаметазоном | |
MX2016006375A (es) | Una combinacion de unidades de dosificacion para su uso en el tratamiento del parto prematuro. |